Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the imagemagick-engine domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /usr/local/data/sites/proginres/htdocs-SSL/wp-includes/functions.php on line 6121

Notice: La funzione _load_textdomain_just_in_time è stata richiamata in maniera scorretta. Il caricamento della traduzione per il dominio ct è stato attivato troppo presto. Di solito è un indicatore di un codice nel plugin o nel tema eseguito troppo presto. Le traduzioni dovrebbero essere caricate all'azione init o in un secondo momento. Leggi Debugging in WordPress per maggiori informazioni. (Questo messaggio è stato aggiunto nella versione 6.7.0.) in /usr/local/data/sites/proginres/htdocs-SSL/wp-includes/functions.php on line 6121
diagnosis – Progress in Research

TROPHY project kicks off

Activities related to the TROPHY (ulTRafast hOlograPHic FT-IR microscopY) project have officially started. TROPHY is a research project, funded by the European Commission under the Horizon Europe programme, which aims to develop a novel label-free vibrational microscopy approach for cancer diagnosis.

Cancer diagnosis is traditionally done on intraoperative frozen tissue sections by post-surgical histopathologic analysis and, in selected cases, by elaborated and time-consuming molecular diagnosis. The analysis of the biopsy is performed through the staining of the tissue and the evaluation of the morphology of its cells under an optical microscope. This approach is neither fast nor quantitative, has an intrinsic variability in the interpretation depending on the experience of the histopathologist, and provides limited molecular information.

The microscope developed thanks to the TROPHY project will image molecular biomarkers with unprecedented speed and chemical selectivity for a rapid, precise, and non-biased tumor analysis. To this purpose, it will blend in a unique fashion elements of several microscopies developed in the past decades, namely photo-thermal infrared, Fourier transform infrared and Digital Holography Microscopy, bringing them to the unprecedented ultrafast timescale. It will also integrate Artificial Intelligence to produce fast results and assist in the tumour grading process even during surgery.

This microscope will be used to assist healthcare professionals during tumor biopsy diagnostics, provide an accurate diagnosis for curative oncosurgery, guarantee complete resection during intervention, determine the best therapeutic approach tailored to the patient, and identify resistant tumor clones under targeted therapy, paving the way for continual precision medicine in cancer.

The project is coordinated by the Politecnico di Milano with Prof. Marco Marangoni from the Department of Physics as scientific coordinator. The other project partners are Fundacio Institut de Ciences Fotoniques (ICFO, Spain), Consiglio Nazionale delle Ricerche (CNR, Italy), Lyncee Tec SA (LT, Switzerland), Universtaetsklinikum Jena (JUH, Germany), University of Exeter (UNEXE, UK), University of Cambridge (UCAM, UK).

A revolution in the diagnosis and treatment of cancer

CHARM is a project aiming to develop a medical device based on high-speed, low-cost Raman digital imaging technology and artificial intelligence to transform cancer diagnosis and treatment.

The technology will analyse the molecular composition of patient tissue samples to distinguish cancerous from healthy cells without the need for chemical staining.

CHARM’s Raman imaging technology uses graphene-based ultra-fast fibre lasers to generate digital images of patient tissue for automatic analysis by artificial intelligence to support diagnosis. Because the images are digital, they can be viewed remotely, allowing histopathologists to work more efficiently and to support regions and countries short of qualified staff. The technology also potentially opens the way for personalised treatments for cancer.

The partners involved are Cambridge Raman Imaging Ltd. (CRI), a polimi spin-off, the University of Cambridge, Consiglio Nazionale delle Ricerche, Politecnico Di Milano, the Jena University Hospital (Germany) and the firms INsociety (Italy) and Inspiralia (Spain). The project coordinator is Dr Matteo Negro, CRI’s Chief Technology Officer.

CHARM is one of the 42 projects selected for a €3.3 million funding from 292 submitted in the first ever EIC (European Innovation Council) Transition Challenges, intended to support moving technologies from laboratories into the real world. The EIC is Europe’s flagship innovation programme to identify, develop and scale up breakthrough technologies and game changing innovations. In the case of CHARM, it aims to develop medical devices to the preclinical validation phase.

Politecnico di Milano, who pioneered the high-speed Raman imaging technology, will be responsible for the development of the microscope and the detection system.

I am excited to contribute to the translation of the results of our scientific studies into a commercial product which promises to significantly improve cancer diagnosis and therapy and have an important societal impact. To foster a close link between fundamental research and technological innovation is one of our main missions as academics and lies at the core of the EIC.

Prof. Giulio Cerullo, head of the ultrafast spectroscopy laboratory at Politecnico di Milano

Questo sito utilizza i cookies per le statistiche e per agevolare la navigazione nelle pagine del sito e delle applicazioni web. Maggiori informazioni sono disponibili alla pagina dell'informativa sulla privacy

Accetto